Financial Enhancement Group LLC Merck & Co., Inc. Transaction History

Financial Enhancement Group LLC

$569 Million
Q3 2024

A detailed history of Financial Enhancement Group LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Financial Enhancement Group LLC holds 81,948 shares of MRK stock, worth $8.04 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

81,948

Previous 43,086 90.2%

Holding current value

$8.04 Million

Previous $5.33 Million 74.47%

% of portfolio

1.63%

Previous 0.87%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$111.15 - $128.97 $4.32 Million - $5.01 Million	38,862 Added 90.2%	81,948 $9.31 Million
Q2 2024 Aug 02, 2024	SELL	$123.8 - $132.96 $145,960 - $156,759	-1,179 Reduced 2.66%	43,086 $5.33 Million
Q1 2024 Apr 15, 2024	SELL	$113.24 - $131.95 $23,214 - $27,049	-205 Reduced 0.46%	44,265 $5.84 Million
Q4 2023 Jan 18, 2024	SELL	$100.18 - $109.02 $1.33 Million - $1.45 Million	-13,290 Reduced 23.01%	44,470 $4.85 Million
Q3 2023 Oct 17, 2023	SELL	$102.95 - $114.33 $33,561 - $37,271	-326 Reduced 0.56%	57,760 $5.95 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $2.59 Million - $2.82 Million	-23,862 Reduced 29.12%	58,086 $6.7 Million
Q1 2023 May 17, 2023	BUY	$102.94 - $114.86 $443,774 - $495,161	4,311 Added 5.55%	81,948 $8.72 Million
Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $6.75 Million - $8.65 Million	77,159 Added 16142.05%	77,637 $8.61 Million
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $3,649 - $4,298	-53 Reduced 9.98%	478 $37,000
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $9,401 - $10,434	131 Added 32.75%	531 $43,000
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $10,281 - $11,698	-146 Reduced 26.74%	400 $31,000
Q1 2020 May 04, 2020	SELL	$63.36 - $87.82 $5.64 Million - $7.82 Million	-89,007 Reduced 99.39%	546 $42,000
Q4 2019 Jan 31, 2020	BUY	$77.58 - $87.54 $152,522 - $172,103	1,966 Added 2.24%	89,553 $8.15 Million
Q3 2019 Nov 08, 2019	BUY	$76.08 - $82.93 $898,504 - $979,403	11,810 Added 15.59%	87,587 $7.37 Million
Q2 2019 Aug 06, 2019	BUY	$69.84 - $81.59 $238,294 - $278,385	3,412 Added 4.71%	75,777 $6.35 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $5.01 Million - $5.71 Million	71,965 Added 17991.25%	72,365 $6.02 Million
Q1 2018 Apr 30, 2018	BUY	$50.96 - $59.23 $20,384 - $23,692	400 New	400 $22,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.

Account

Financial Enhancement Group LLC Merck & Co., Inc. Transaction History